1. Home
  2. TOMZ vs VTGN Comparison

TOMZ vs VTGN Comparison

Compare TOMZ & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

N/A

Current Price

$1.91

Market Cap

11.9M

Sector

Finance

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

N/A

Current Price

$0.17

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TOMZ
VTGN
Founded
1979
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9M
9.5M
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
TOMZ
VTGN
Price
$1.91
$0.17
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $1.00
AVG Volume (30 Days)
25.2K
★ 846.7K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 13.64
N/A
EPS
★ N/A
N/A
Revenue
★ $5,635,927.00
N/A
Revenue This Year
$111.80
$33.96
Revenue Next Year
$52.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.21
$0.17
52 Week High
$9.73
$5.14

Technical Indicators

Market Signals
Indicator
TOMZ
VTGN
Relative Strength Index (RSI) 68.25 29.12
Support Level $1.28 N/A
Resistance Level $1.95 $0.32
Average True Range (ATR) 0.20 0.01
MACD 0.04 -0.00
Stochastic Oscillator 80.24 6.37

Price Performance

Historical Comparison
TOMZ
VTGN

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: